awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34734676-A13DC163-82A6-412D-817D-E31762B11751
Q34734676-A13DC163-82A6-412D-817D-E31762B11751
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34734676-A13DC163-82A6-412D-817D-E31762B11751
Successful management of enzyme replacement therapy in related fabry disease patients with severe adverse events by switching from agalsidase Beta (fabrazyme(®)) to agalsidase alfa (replagal (®)).
P2860
Q34734676-A13DC163-82A6-412D-817D-E31762B11751
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34734676-A13DC163-82A6-412D-817D-E31762B11751
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
fca68d5b9761e1ca76a643fb3206e38e461a5bf1
P2860
Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.